Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012

Gastroenterology

Volumn 152, Issue 4, 2017, Pages 812-820.e5

  White, Donna L ^a,b   Thrift, Aaron P ^a   Kanwal, Fasiha ^a,b   Davila, Jessica ^a,b   El Serag, Hashem B ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidemiology; HBV; NAFLD; USCS

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL LIVER DISEASE; AMERICAN INDIAN; ARIZONA; ARTICLE; ASIAN AMERICAN; CALIFORNIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; FLORIDA; HAWAII; HEPATITIS B; HEPATITIS C; HISPANIC; HUMAN; IDAHO; ILLINOIS; KANSAS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK; NONALCOHOLIC FATTY LIVER; NORTH DAKOTA; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; TEXAS; URBAN AREA; UTAH; AGE; CARCINOMA, HEPATOCELLULAR; CAUCASIAN; ETHNOLOGY; INCIDENCE; LIVER NEOPLASMS; REGISTER; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CARCINOMA, HEPATOCELLULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85014317452     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.11.020     Document Type: Article

References (26)

1. 1 Singal, A.G., El-Serag, H.B., Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol 13 (2015), 2140–2151.
2. 2 Altekruse, S.F., Henley, S.J., Cucinelli, J.E., et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 109 (2014), 542–553.
3. 3 Petrick, J.L., Kelly, S.P., Altekruse, S.F., et al. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol 34 (2016), 1787–1794.
4. 4 Ahmed, F., Perz, J.F., Kwong, S., et al. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis, 5, 2008, A74.
5. 5 U.S. Cancer Statistics Working Group. United States Cancer Statistics 1999-2012 incidence and mortality web-based report. US Department of Health and Human Services, 2015. www.cdc.gov/uscs. Accessed: July 1, 2016.
6. 6 Fritz A, Percy C, Jack A, ed., et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
7. 7 US Department of Health and Human Services. United States Cancer Statistics: 1999-2012. US Department of Health and Human Services, 2015. https://www.cdc.gov/cancer/npcr/uscs/download_data.htm. Accessed February 3, 2017.
8. 8 Tiwari, R.C., Clegg, L.X., Zou, Z., Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 15 (2006), 547–569.
9. 9 Yu B, Barrett MJ, Kim H-J, et al. Estimating joinpoints in continuous time scale for multiple change-point models. Bethesda: Statistical Research and Applications Branch, National Cancer Institute, 2006.
10. 10 Kim, H.J., Fay, M.P., Feuer, E.J., et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000), 335–351.
11. 11 Njei, B., Rotman, Y., Ditah, I., et al. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61 (2015), 191–199.
12. 12 Ryerson, A.B., Eheman, C.R., Altekruse, S.F., et al. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 122 (2016), 1312–1337.
13. 13 Gordon, S.C., Lamerato, L.E., Rupp, L.B., et al. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. Clin Gastroenterol Hepatol 12 (2014), 885–893.
14. 14 El-Serag, H.B., Lau, M., Eschbach, K., et al. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 167 (2007), 1983–1989.
15. 15 Armstrong, G.L., Wasley, A., Simard, E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006), 705–714.
16. 16 Setiawan, V.W., Wei, P.C., Hernandez, B.Y., et al. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: the Multiethnic Cohort. Cancer 122 (2016), 1444–1452.
17. 17 Browning, J.D., Szczepaniak, L.S., Dobbins, R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004), 1387–1395.
18. 18 Kallwitz, E.R., Daviglus, M.L., Allison, M.A., et al. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clin Gastroenterol Hepatol 13 (2015), 569–576.
19. 19 Mittal, S., Sada, Y.H., El-Serag, H.B., et al. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol 13 (2015), 594–601.
20. 20 El-Serag, H.B., Kramer, J., Duan, Z., et al. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol 109 (2014), 1427–1435.
21. 21 Farrell, G., Insulin resistance, obesity, and liver cancer. Clin Gastroenterol Hepatol 12 (2014), 117–119.
22. 22 Chhatwal, J., Kanwal, F., Roberts, M.S., et al. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med 162 (2015), 397–406.
23. 23 El-Serag, H.B., Kramer, J., Duan, Z., et al. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat 23 (2016), 687–696.
24. 24 El-Serag, H.B., Kanwal, F., Richardson, P., et al. Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection. Hepatology 64 (2016), 130–137.
25. 25 Yalamanchili, K., Saadeh, S., Lepe, R., et al. The prevalence of hepatitis C virus infection in Texas: implications for future health care. Proc (Bayl Univ Med Cent) 18 (2005), 3–6.
26. 26 Ramirez, A.G., Munoz, E., Holden, A.E., et al. Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update. PLoS One, 9, 2014, e99365.